Scleral lenses and ocular surface disease
Scleral lenses provide patients with many benefits and are an extremely useful adjunct in treating patients with ocular surface disease, writes Damon Ezekiel
News
more... optometry | ophthalmology
-
Rodenstock’s Australasian expansion plansSeptember 24, 2023
-
Trial success for IV TED treatmentSeptember 23, 2023
-
ERO launches Project GreenSeptember 23, 2023
-
Progress for DED peptide treatmentSeptember 21, 2023
-
Identifying inflammation in dry eye diseaseSeptember 20, 2023
-
Māori’s higher treatment-injury riskSeptember 20, 2023
Editor's Choice
more... editor's choice
-
Equitable Māori eye health in practiceSeptember 22, 2023
-
Should we put the eye into AI?September 20, 2023
-
Covid and ocular surface diseaseSeptember 18, 2023
Equitable Māori eye health in practice
Ocular health disparities between Māori and non-Māori are well-recognised1, with current epistemologies of Western medicine failing to acknowledge the...
Should we put the eye into AI?
OK, I’ll admit it: as a journalist and copywriter, I use the artificial intelligence (AI) language model ChatGPT. Before your opinion of me sours, let...
Covid and ocular surface disease
In February of 2021, a 42-year-old woman was referred to our ocular surface disease clinic with ongoing symptoms of dry eye following her SARSCoV2 (Covid)...
Features
more... optometry | ophthalmolgy
Dry and cosmetics: what does the research tell us
The quest to enhance human beauty with eye makeup began thousands of years ago. Today it continues with an unremitting passion. But there is a dark side...
Inflammasomes and DED
The optimal management of dry eye disease (DED) often seems an enigma. A recently published collaborative review, by Ocular Surface Laboratory (OSL) and...
NZ Optics Magazine
